ATAI - atai Life Sciences N.V. (ATAI) CEO Florian Brand on Q4 2021 Results - Earnings Call Transcript
atai Life Sciences N.V. (ATAI) Q4 2021 Results Earnings Conference Call March 30, 2022, 08:30 AM ET Company Participants Colin Keeler - Manager, Corporate Finance Christian Angermayer - Founder and Chairman Florian Brand - Co-Founder, Chief Executive Officer and Managing Director Srinivas Rao - Co-Founder and Chief Scientific Officer Greg Weaver - Chief Financial Officer and Managing Director Conference Call Participants Andrew Tsai - Jefferies LLC Neena Bitritto-Garg - Citi Investment Research (US) Charles Duncan - Cantor Fitzgerald Ritu Baral - Cowen and Company Judah Frommer - Credit Suisse Securities (USA) LLC Brian Abrahams - RBC Capital Markets Patrick Trucchio - H.C. Wainwright & Co. Sumant Kulkarni - Canaccord Genuity Presentation Colin Keeler Good morning. And welcome the atai Life Sciences Fourth Quarter and Year-End 2021 Financial Results and Corporate Update Conference Call. Currently all participants are in a listen-only mode. After the speakers' presentation, there will be an open
For further details see:
atai Life Sciences N.V. (ATAI) CEO Florian Brand on Q4 2021 Results - Earnings Call Transcript